Literature DB >> 31534251

Towards a universal flu vaccine.

Michael Eisenstein.   

Abstract

Entities:  

Keywords:  Diseases; Drug discovery; Medical research; Vaccines

Year:  2019        PMID： 31534251     DOI： 10.1038/d41586-019-02751-w

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  A Review and Meta-Analysis of Influenza Interactome Studies.

Authors:  Sonja Courtney Jun Hui Chua; Jianzhou Cui; David Engelberg; Lina Hsiu Kim Lim
Journal:  Front Microbiol       Date:  2022-04-21       Impact factor: 6.064

Review 2.  Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.

Authors:  Angelika Wagner; Birgit Weinberger
Journal:  Front Immunol       Date:  2020-04-23       Impact factor: 7.561

3.  Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.

Authors:  Chloe H Lee; Mariana Pereira Pinho; Paul R Buckley; Isaac B Woodhouse; Graham Ogg; Alison Simmons; Giorgio Napolitani; Hashem Koohy
Journal:  Front Immunol       Date:  2020-11-05       Impact factor: 7.561

Review 4.  Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review.

Authors:  Bahar Behrouzi; Maria Viviana Araujo Campoverde; Kyle Liang; H Keipp Talbot; Isaac I Bogoch; Allison McGeer; Ole Fröbert; Mark Loeb; Orly Vardeny; Scott D Solomon; Jacob A Udell
Journal:  J Am Coll Cardiol       Date:  2020-10-13       Impact factor: 24.094

Review 5.  Influenza and Influenza Vaccine: A Review.

Authors:  Cynthia Nypaver; Cynthia Dehlinger; Chelsea Carter
Journal:  J Midwifery Womens Health       Date:  2021-02-01       Impact factor: 2.388

Review 6.  Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination.

Authors:  Bahar Behrouzi; Jacob A Udell
Journal:  Curr Atheroscler Rep       Date:  2021-10-21       Impact factor: 5.113

7.  A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice.

Authors:  Yongbo Qiao; YaXin Zhang; Jie Chen; Shenghui Jin; Yaming Shan
Journal:  Nano Res       Date:  2022-07-01       Impact factor: 10.269

Review 8.  Eliciting B cell immunity against infectious diseases using nanovaccines.

Authors:  Ankur Singh
Journal:  Nat Nanotechnol       Date:  2020-11-16       Impact factor: 39.213

9.  The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.

Authors:  Michael G Head; Rebecca J Brown; Marie-Louise Newell; J Anthony G Scott; James Batchelor; Rifat Atun
Journal:  Lancet Glob Health       Date:  2020-10       Impact factor: 26.763

Review 10.  The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines.

Authors:  Rossella Cianci; Laura Franza; Maria Grazia Massaro; Raffaele Borriello; Francesco De Vito; Giovanni Gambassi
Journal:  Vaccines (Basel)       Date:  2020-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.